Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual alfentanil for pain relief during prostate biopsy
2011-001903-10Phase 2Completed
- Sponsor
- Orexo AB
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in procedural pain comparing Sublingual alfentanil with Placebo (2 arms). Primary endpoint: Worst pain intensity during prostate biopsy. Started Jul 2012; status: completed.
02
Drugs
alfentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on 2011-001903-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001903-10.